Semler Scientific, Inc. (SMLR)
Chart Events
Performance Outlook
| Previous Close | 36.27 |
| Open | 36.00 |
| Bid | 36.09 x 1100 |
| Ask | 36.80 x 1100 |
| Day's Range | 31.50 - 36.40 |
| 52 Week Range | 26.70 - 82.00 |
| Volume | |
| Avg. Volume | 32,973 |
| Market Cap | 244.629M |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 18.00 |
| EPS (TTM) | 2.01 |
| Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.50 |
- PR Newswire
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home screening. AJPM Focus is the official open access journal jointly launched this year by both The American College of Preventive Medi
- PR Newswire
Semler Announces Investment in Monarch Medical Technologies
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured by a first priority interest in all of Monarch's assets.
- PR Newswire
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2022.
